Key facts
- This page summarizes Andrew Sinclair's Form 4 filing for SOLENO THERAPEUTICS INC (SLNO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Oct 2022, 18:31.
Andrew Sinclair - 01 Jun 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)
- Reporting relationship
- Director
- Issuer ticker
- SLNO
- Reported as of
- 01 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Oct 2022, 18:31:20 UTC
- Prior SEC filing
- 31 Mar 2022
- Next SEC filing
- 03 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Anish Bhatnagar, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew Sinclair filed Form 4 for SOLENO THERAPEUTICS INC (SLNO) on 14 Oct 2022.
Change
- Previous filing in this sequence was filed on 31 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SLNO
transaction
Derivative
Stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +2,666
- Change %
- Price
- $0.000000
- Shares after
- 2,666
- Date
- 01 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,666
- Exercise price
- $2.55
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022.
Footnote F2
The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of June 1, 2022 or the day before the next annual stockholder meeting, subject to Reporting Person continuing to be a Service Provider through each such date.